Biotech Showcase

Biotech Showcase | January 13–15, 2025 | San Francisco, CA

Mabion will once again be attending the Biotech Showcase this January!

This event is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharma executives. It is the exquisite platform for Mabion to strengthen our position and forge new partnerships in the US market. The event brings together a diverse spectrum of companies, spanning from early-stage ventures to mid- and later-stage companies. In San Francisco will be over 400 companies and an impressive USD 400 billion in capital represented.

Mabion representatives at the event will be:

• Adam Pietruszkiewicz, Chief Commercial Officer
• Marty Henehan, VP of Business Development – Head of North America

We remain open to the needs of our customers. We will present both a comprehensive gene to vial offer and dedicated standalone analytical solutions. These include drug characterization, product/process-related impurities assessment, bioanalytical methods and release testing. We are looking forward to meaningful discussions and opportunities to drive innovation in the biotech and biopharma space.

Check out the Biotech Showcase website for more details about this incredible show.